M
MRM HEALTH
MRM Health is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent and has a strategic partnership with the ...
Company Email ：hr@mrmhealth.com
Industry ：Business ServicesBusiness Services General
Company address ：2 February 2021, Gent, Flanders, Belgium
Company website ：*****
Company phone ：+32 92411188
Established ：2020
Company Revenue ：$6,583,000
Number of employees ：26
SIC Code ：87873
NAICS Code ：54541
Main Products ：TechnologyPipeline
Company News
MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
Sep 19, 2023
GHENT, Belgium--(BUSINESS WIRE)-- #Parkinson--MRM Health NV, a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics, today reports positive topline results from its Phase 2a clinical trial with MH002 in mild-to-moderate Ulcerative Colitis (UC). MRM Health’s MH002-UC-201 study was a multi-center, double-blind, randomized, placebo-controlled trial in 45 UC patients at multiple clinical sites in Belgium, Poland and Czech Republic. The
Sep 19, 2023
MRM Health Appoints Katja Conrath as Chief Scientific OfficerJun 7, 2023
GHENT, Belgium--(BUSINESS WIRE)-- #Parkinson--MRM Health - a clinical-stage biopharmaceutical company focused on developing innovative microbiome-based biotherapeutics based on its proprietary and unique CORAL® platform technology - today announced that it appointed Katja Conrath, PhD, as Chief Scientific Officer. Dr. Conrath brings more than 15 years of experience in drug discovery and early development in various indications, among which fibrosis and inflammation. She will oversee MRM Health’s
Jun 7, 2023MRM Health Completes Patient Recruitment in Ulcerative Colitis Study, Secures Financing and Provides Outlook for 2023Mar 7, 2023
GHENT, Belgium--(BUSINESS WIRE)-- #Parkinson--MRM Health—a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics based on its proprietary and unique CORAL® platform technology - today provided a business update on its different ongoing therapeutic programs and an outlook for 2023. Key anticipated milestones for 2023: - Top-line data from Phase 2a trial with MH002 in Ulcerative Colitis in Q3 2023 and mechanistic readouts in Q4 2023 -
Mar 7, 2023MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes ProgramDec 13, 2022
GHENT, Belgium--(BUSINESS WIRE)-- #NAFLD--MRM Health—a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics—today announced that its Type-2 Diabetes Program, developed in collaboration with IFF (NYSE: IFF) has achieved preclinical development targets. With the achievement of this new milestone, both companies will now advance this research which focuses on developing innovative therapies for metabolic diseases to the clinical devel
Dec 13, 2022MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in PouchitisJun 28, 2022
GHENT, Belgium--(BUSINESS WIRE)-- #Parkinson--MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced today that they have received regulatory approval from the Federal Agency for Medicines and Health Products (FAMHP) in Belgium to start a Phase 2 trial with the novel next-generation optimized consortium therapy, MH002, in patients with Pouchitis. MH002 is the first, rationally designed, consortium therapy, in which key
Jun 28, 2022Web Summary
Q1: What is the address of MRM Health's headquarters?
A1: The address of MRM Health's headquarters is Technologiepark 73, 9052 Ghent, Belgium.
Q2: What type of products does MRM Health develop?
A2: MRM Health develops next-generation live microbiome consortia therapeutics, which are novel class of effective, disease-modifying and safe therapeutics based on optimized consortia of live bacteria.
Q3: In what industry is MRM Health primarily involved?
A3: MRM Health is primarily involved in the biopharmaceutical industry, specifically focusing on the development of microbiome-based therapeutics.
Q4: What services does MRM Health offer?
A4: Although not explicitly stated in the provided text, based on the information given, it can be inferred that MRM Health offers clinical trial management, regulatory affairs, manufacturing, and research services for its clients. Additionally, the company provides end-to-end development capabilities from discovery to CMC (Clinical Manufacturing).
Q5: What is the name of MRM Health's proprietary technology platform?
A5: The name of MRM Health's proprietary technology platform is CORALâ¢.
Q6: Who is the founder or key figure behind MRM Health's concept?
A6: Willy Verstraete, Prof. Em. Microbial Ecology, Ghent University, Belgium, is mentioned as a key figure who has translated the MRM concept into the CORAL⢠technology platform.
Q7: What is the name of the Type-2 Diabetes program developed by MRM Health in collaboration with IFF?
A7: The name of the Type-2 Diabetes program developed by MRM Health in collaboration with IFF is not explicitly stated, but it has achieved preclinical development targets based on its proprietary and unique CORAL⢠platform technology.
Q8: What is the main goal or mission of MRM Health?
A8: The main goal or mission of MRM Health is to develop first-in-class therapeutics by harnessing the full power of the gut microbiome, with a focus on restoring metabolic networks and functional niches to improve host-microbiome interactions.
A1: The address of MRM Health's headquarters is Technologiepark 73, 9052 Ghent, Belgium.
Q2: What type of products does MRM Health develop?
A2: MRM Health develops next-generation live microbiome consortia therapeutics, which are novel class of effective, disease-modifying and safe therapeutics based on optimized consortia of live bacteria.
Q3: In what industry is MRM Health primarily involved?
A3: MRM Health is primarily involved in the biopharmaceutical industry, specifically focusing on the development of microbiome-based therapeutics.
Q4: What services does MRM Health offer?
A4: Although not explicitly stated in the provided text, based on the information given, it can be inferred that MRM Health offers clinical trial management, regulatory affairs, manufacturing, and research services for its clients. Additionally, the company provides end-to-end development capabilities from discovery to CMC (Clinical Manufacturing).
Q5: What is the name of MRM Health's proprietary technology platform?
A5: The name of MRM Health's proprietary technology platform is CORALâ¢.
Q6: Who is the founder or key figure behind MRM Health's concept?
A6: Willy Verstraete, Prof. Em. Microbial Ecology, Ghent University, Belgium, is mentioned as a key figure who has translated the MRM concept into the CORAL⢠technology platform.
Q7: What is the name of the Type-2 Diabetes program developed by MRM Health in collaboration with IFF?
A7: The name of the Type-2 Diabetes program developed by MRM Health in collaboration with IFF is not explicitly stated, but it has achieved preclinical development targets based on its proprietary and unique CORAL⢠platform technology.
Q8: What is the main goal or mission of MRM Health?
A8: The main goal or mission of MRM Health is to develop first-in-class therapeutics by harnessing the full power of the gut microbiome, with a focus on restoring metabolic networks and functional niches to improve host-microbiome interactions.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
